Oxaliplatin Injection |
Eloxatin |
Pictures
Eloxatin250x170 jpg
Picture of Eloxatin
2259 jpg
Survival data were not mature at the time of the analysis with a median follow up of 47 months No statistically significant difference in overall survival Hazard Ratio 0 89 95
2260 jpg
A descriptive subgroup analysis demonstrated that the improvement in survival for ELOXATIN plus 5 FU LV compared to irinotecan plus 5 FU LV appeared to be maintained across age
AdjuvantKMCurve0001 jpg
ITT analysis Figure 2 shows the Kaplan Meier DFS curves for the comparison of ELOXATIN and infusional 5 FU LV combination and infusional 5 FU LV alone for the Stage III Subgroup Figure 1 Kaplan Meier DFS curves by treatment arm for Overall Population
AdjuvantKMCurve0002 jpg
Figure 1 Kaplan Meier DFS curves by treatment arm for Overall Population Figure 2 Kaplan Meier DFS curves by treatment arm for Stage III Subgroup Survival data were not mature at the time of the analysis with a median follow up of 47 months
766 SANOFI AVENTIS
figure1 gif
Figure 3 illustrates the Kaplan Meier survival curves for the comparison of ELOXATIN and 5 FU LV combination and ELOXATIN plus irinotecan to irinotecan plus 5 FU LV Figure 3 Kaplan Meier Overall Survival by treatment arm A descriptive subgroup analysis demonstrated that the improvement in survival for ELOXATIN plus 5 FU LV compared to
2006427101811238 jpg
Name Oxaliplatin for Injection Composition Each vial contains 50mg of Oxaliplatin Indications For the treatment of patients with metastatic carcinoma of the colon or rectum whose disease
D38A4322 A22B 4EC6 965C AFF537A1A5AA jpg
oxaliplatin injection Prescribing Information Including Black Box Warning
edaenteeloxatininjection jpg
2257 jpg
The molecular weight is 397 3 Oxaliplatin is slightly soluble in water at 6 mg mL very slightly soluble in methanol and practically insoluble in ethanol and acetone
oxyfparepaclitaxelinjectioninjectable jpg
PACLITAXEL Injection Injectable

Not Signed In -

